Evogene vs SenesTech
EVGN and SNES side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EVGN and SNES compare
SenesTech grew revenue faster over the last twelve months (13.4% versus −30.9% for Evogene).
Evogene keeps more of each dollar of sales as profit, with a net margin of −220% compared with −295% at SenesTech.
SenesTech scores higher on the StockData Score (10 against 3 for Evogene), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EVGN | SNES |
|---|---|---|
| Size and price | ||
| Market cap | – | $4.8M |
| Share price | $0.395 | $0.893 |
| Change, 1 year | −66.6% | −74.4% |
| Change, 5 years | −98.1% | −100.0% |
| Beta (5Y) | 1.04 | 0.84 |
| Employees | 78 | 23 |
| StockData Score | ||
| Total score | 3 | 10 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 1 |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 2.0× |
| P/B | – | 0.8× |
| FCF yield | – | −139% |
| Fair value | – | $2.20 |
| Margin of safety | – | 59.5% |
| Growth | ||
| Revenue growth (TTM) | −30.9% | 13.4% (better) |
| Revenue growth, 5Y average | 29.9% | 51.1% (better) |
| Profitability | ||
| Gross margin | −6.3% | 66.2% (better) |
| Operating margin | −364% | −304% (better) |
| Net margin | −220% (better) | −295% |
| FCF margin | −354% | −284% (better) |
| Return on equity | – | −107% |
| Return on invested capital | – | −528% |
| Financial health | ||
| Debt / equity | – | 0.02 |
| Interest coverage | −7.3× (better) | −360.4× |
| Current ratio | 3.57 | 6.78 (better) |
| Altman Z-score | – | −22.43 |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −3.6% |
| Shareholder yield | – | −3.6% |
| Ownership | ||
| Held by institutions | 3.2% | 9.1% |
| Held by insiders | 50.7% | 46.5% |
| Insider net buying, 12 months | $695K | $1.8M (better) |
| Short interest, % of float | 1.6% | 1.4% |
Go deeper
- EVGN stock overview
- EVGN income statement
- EVGN valuation and score
- SNES stock overview
- SNES income statement
- SNES valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.